ADAM17 is implicated in the pathogenesis of colorectal cancer (CRC), with its elevated expression correlating with tumor progression, including deeper invasion, lymph node metastasis, and distant metastasis (Chen et al., 2024). This evidence concerns the gene ADAM17 and neoplasm.